Oligonucleotide Purification

What is Oligonucleotide Purification?

Oligonucleotide purification is the process of isolating full-length synthetic DNA or RNA sequences from impurities that arise during chemical synthesis. These impurities may include truncated sequences, incomplete coupling products, residual protecting groups, salts, and organic reagents. Purification ensures that only the desired oligonucleotide having the correct sequence and chemical structure is recovered for use in downstream applications such as PCR, gene synthesis, and therapeutic development. Accurate and efficient oligonucleotide purification is therefore a critical step in ensuring sequence integrity, purity, and reproducibility across research and manufacturing workflows.

Phenomenex Oligonucleotide Purification Portfolio

Our oligonucleotide portfolio, including columns and sample preparation solutions, is designed to efficiently and effectively purify and characterize synthetic oligonucleotides used in biological research, therapeutic development, and biochemical manufacturing.

Why Purification is Critical in Oligo Synthesis?

While the oligonucleotide synthesis chemistry is very efficient, each cycle generates a number of closely related impurities. The result is a mixture of the desired full-length sequence oligonucleotide and other less abundant forms, including longer and/or shorter sequences, and sequences that can carry unexpected modifications, such as incomplete deprotected groups, deamidation and oxidation. For this reason, oligonucleotide purification is a key process for the efficient recovery of pure full-length sequence oligonucleotides.

Therefore, oligo purification is essential to obtain homogeneous, high-purity sequences suitable for sensitive downstream applications such as qPCR, antisense therapy, or CRISPR guide design. Purification also improves stability and ensures accurate quantitation, which is particularly important for large-scale or therapeutic-grade oligonucleotide production.

Common Oligonucleotide Purification Methods

A range of oligonucleotide purification methods are employed depending on the required purity level and application scale. The most widely used chromatography-based approaches include:

Desalting (Quick Purification)
Desalting refers to a group of rapid purification approaches used to remove small molecule impurities such as salts and residual synthesis reagents following oligonucleotide synthesis. Various technologies can be employed for desalting or buffer exchange, including size exclusion–based spin columns, or ion-pairing reversed-phase chromatography. Desalting provides moderate purity suitable for screening or routine PCR use.

SPE Purification

Solid-phase extraction (SPE) purification of oligonucleotides using reversed-phase provides improved purity by removing truncated sequences and hydrophobic by-products. This method can be carried out directly under reversed-phase mode, for oligonucleotides carrying the trityl protective groups, or using ion pairing reagents, for recently synthesised trityl-off oligonucleotides. These approaches are ideal for medium-throughput workflows.

To see how purification fits into the complete process, explore our Oligonucleotide Solution Workflow Infographic, which highlights how Phenomenex supports a streamlined and reliable workflow from purification through final analysis. Discover solutions that enable efficient impurity removal, high recovery of diverse oligo types, robust and selective chromatographic separation, and clean, consistent sample handling.

HPLC Purification of Oligonucleotides
Ion-pair reversed-phase (IP-RP) and anion-exchange (AEX) HPLC methods deliver the highest purity by separating full-length oligos based on hydrophobicity or charge. Preparative and semi-preparative HPLC are preferred for large-scale purification, ensuring reproducibility and scalability for manufacturing. These workflows require method optimization to effectively balance purity, recovery, and throughput to maximize process efficiency.

How Oligonucleotide Purification Works

The working principle of oligonucleotide purification relies on differential interactions between the oligonucleotide, the stationary phase and the mobile phase used. For example:

  • Ion-Pair Reversed-phase (RP) purification utilizes a charged, surfactant-like reagent capable of forming ion-pair complexes with ionic analytes - such as oligonucleotides - enhancing their hydrophobicity and enabling separation through hydrophobic interactions with the stationary phase.
  • Anion-exchange (AEX) purification exploits differences in net negative charge among oligonucleotide variants.
  • Desalting can also be achieved by size exclusion principles, removing low-molecular-weight impurities.

Choosing the Right Oligo Purification Method
Selecting the optimal oligo purification method depends on several key factors:

Application Requirements
Diagnostic, research, or therapeutic applications require different purity levels. Analytical-grade purity may suffice for research, while therapeutic oligos demand >98% purity.

Oligonucleotide Length
Longer sequences (>40 bases) often exhibit stronger hydrophobic interactions in IP-RP and may require gradient optimization for complete separation.

Presence of Modifications
Fluorophores, linkers, or phosphorothioate groups can affect retention behavior, guiding the choice between RP or ion-exchange modes.

Yield Considerations
High-throughput labs and production environments prioritize scalable methods. Semi-preparative or preparative HPLC, using larger particle-size columns, ensures robust yield without compromising purity.

Efficient purification drives better yield, lower costs, and consistent performance. Explore solutions for every scale—from prep columns to bulk media for large-scale separations.

Prep Scale Options

Clarity Oligo-RP columns in 5 µm and 10 µm particle sizes for robust reversed-phase purification.

Bulk Media for Process Scale

HPLC media for reversed phase, normal phase, and chiral chemistries to support high-volume workflows.

FAQs

Typically ion-pairing reagents are used to increase the retention and resolution of oligo’s separated by reversed-phase HPLC. High molarity amounts (100 mM triethylamine acetate [TEAA]) are typically added when analyzing oligonucleotides, however the high level of TEAA leads to ion suppression that makes MS detection of oligonucleotides difficult at therapeutic and reagent concentrations. With LCMS we recommend hexafluoroisopropanol (HFIP) as a mobile-phase additive which has enabled reasonable sensitivity by MS. Our standard recommendation is 100mM HFIP and 4mM TEA in both A and B of a gradient mixture however more recent studies have shown some oligonucleotides work well even at concentrations as low as 10mM HFIP.
The alkylamine used directly affects retention time, with longer chains leading to increased retention, e.g. hexylamine will show longer retention times than triethylamine. There is also a difference in solubility so generally gradients need to be adjusted to allow for this. Generally, the effect of ion-pair is oligo-specific; for example, Gapmers longer amines offer better resolution whereas for siRNA shorter amines offer an improvement in resolution
Phosphorothioate (PS) can frequently desulfurize in to Phosphodiester (PO) and can result in reduced recoveries during solid phase extraction and sample clean-up step. To abstain PS in oxidizing back to PO we can add anti-oxidants like Cysteine in to the loading buffers. For e.g. in Clarity OTX Loading / Lysis buffer add approx. 1gm Cysteine in 1L bottle of the buffer.
When stored lyophilized at –20 °C and protected from light and moisture, oligonucleotides remain stable for up to two years. In aqueous solution, stability depends on buffer composition and temperature.
Desalting removes only small-molecule contaminants such as salts and solvents, while purification separates full-length oligonucleotides from truncated and modified impurities.
In trityl-on purification, the 5′-trityl protecting group is retained during reversed-phase chromatography, enhancing hydrophobic separation of full-length sequences from failures. The trityl group is then removed post-purification.